(Q56986303)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20966900%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

title

Cognitive-behavioral treatment of nonalcoholic Fatty liver disease: a propensity score-adjusted observational study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20966900%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

1 reference

metabolic dysfunction–associated steatotic liver disease

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20966900%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Giulio Marchesini

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20966900%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

7

Riccardo Dalle Grave

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20966900%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

author name string

Simona Moscatiello

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20966900%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Raffaella Di Luzio

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20966900%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Alessandro Suppini

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20966900%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Silvia Di Domizio

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20966900%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Elisabetta Bugianesi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20966900%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

language of work or name

English

0 references

publication date

21 October 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20966900%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20966900%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20966900%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20966900%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

page(s)

763-770

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20966900%20AND%20SRC:MED&resulttype=core&format=json

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

15 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.254

Diagnosis and therapy of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.254

Long-term follow-up of patients with NAFLD and elevated liver enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.254

Hepatic effects of dietary weight loss in morbidly obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.254

One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.254

New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.254

Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.254

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.254

Behavior therapy for nonalcoholic fatty liver disease: The need for a multidisciplinary approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.254

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.254

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.254

Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.254

Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.254

Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.254

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.254

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.254

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.254

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.254

Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.254

Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.254

Updated definitions of healthy ranges for serum alanine aminotransferase levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.254

Efficacy of lifestyle modification for long-term weight control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.254

Are behavioural approaches feasible and effective in the treatment of type 2 diabetes? A propensity score analysis vs. prescriptive diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.254

Effectiveness of cognitive-behavioral therapy based on the Mediterranean diet for the treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.254

The design versus the analysis of observational studies for causal effects: parallels with the design of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.254

Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.254

Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.254

High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.254

Alanine aminotransferase and the 6-year risk of the metabolic syndrome in Caucasian men and women: the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.254

Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.254

A physical activity program to reinforce weight maintenance following a behavior program in overweight/obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.254

Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.254

High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.254

Potential strategies to improve uptake of exercise interventions in non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.254

The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.254

A decision analysis study of the value of a liver biopsy in nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.254

Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.254

Weight control practices of U.S. adults trying to lose weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.254

Weight loss expectations in obese patients seeking treatment at medical centers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.254

Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.254

The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.254

Pounds off with empowerment (POWER): a clinical trial of weight management strategies for black and white adults with diabetes who live in medically underserved rural communities

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.254

Obesity management in liver clinics: Translation of research into clinical practice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.254

Role of leisure-time physical activity in nonalcoholic fatty liver disease: a population-based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.254

Independent effects of physical activity in patients with nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.254

31 March 2020

Identifiers

DOI

10.1038/OBY.2010.254

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20966900%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference